YOLFTbeta
30

Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd

300313 · SHE · Consumer Defensive / Farm Products

10.44CNY-0.02 (-0.19%)

Price History

Full chart

Market Stats

Previous Close10.46
Open10.37
Day Range9.88 – 10.73
52-Week Range6.89 – 17.80
Volume24.18M
Market Cap2.89B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.05
Dividend Yield0.00%
Beta0.23
50-Day Avg11.79
200-Day Avg9.14

About

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in the provision of cattle breeding products and services in China. The company offers frozen semen and embryos of self-produced breeding bulls, including breeds of Simmental, Brown, Holstein, Angus, Jersey, West Coast, and Charolais; Nine breeds of Limousin and Wagyu cattle; fattening cattle; and sheep frozen semen and embryo products. It is also involved in the young breeding of cows and pregnant cows; livestock technology information; technical services; live cattle and sheep; fresh meat products; ranch and agricultural land management and leasing services; and feed business. It serves live cattle circulation, slaughtering, and processing industry chains. Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. was incorporated in 2003 and is headquartered in Changji, China.

Company Details

  • SectorConsumer Defensive
  • IndustryFarm Products
  • CEOMr. Minghui Han
  • Employees116
  • HeadquartersNo. 569, Beijing North Road, Changji, China, 831100, China
  • Websitehttps://xjtssw.com

Leadership

  • Mr. Minghui HanCo-President, Secretary to the Board & Director · b. 1987
  • Mr. Qiang LiDeputy GM & Non-Independent Director · b. 1972
  • Mr. Jianjun GeVice President · b. 1975
  • Mr. Jie ChenVP & Non-Independent Director · b. 1987

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue22.30M33.71M52.52M75.48M82.00M82.66M121.94M246.87M375.21M195.31M105.23M229.01M163.31M107.98M76.35M137.50M137.60M200.29M
Growth (%)-+51.12%+55.81%+43.73%+8.64%+0.80%+47.53%+102.45%+51.99%-47.95%-46.12%+117.63%-28.69%-33.88%-29.29%+80.09%+0.07%+45.56%
Cost of Revenue9.43M15.19M20.67M33.05M47.56M45.85M77.75M204.53M443.21M118.96M80.13M212.90M136.95M105.06M67.06M122.12M155.70M185.47M
Gross Profit12.87M18.52M31.84M42.43M34.44M36.81M44.20M42.34M-68.00M76.34M25.10M16.10M26.36M2.92M9.29M15.38M-18.10M14.82M
Gross Margin57.70%54.94%60.63%56.21%42.00%44.53%36.24%17.15%-18.12%39.09%23.85%7.03%16.14%2.70%12.17%11.19%-13.15%7.40%
Operating Expense9.54M7.37M10.79M18.91M24.39M28.01M44.57M91.10M123.82M65.18M1.87B108.38M34.32M31.04M37.53M34.04M43.24M20.00M
Operating Income3.33M11.15M21.05M23.53M10.06M8.80M-371.93K-48.77M-191.81M11.17M-1.84B-92.27M-7.97M-28.12M-28.24M-18.66M-61.34M-5.19M
Operating Margin14.95%33.09%40.08%31.17%12.26%10.65%-0.31%-19.75%-51.12%5.72%-1751.12%-40.29%-4.88%-26.05%-36.99%-13.57%-44.58%-2.59%
EBITDA9.19M17.11M30.52M33.41M29.21M23.37M20.87M-14.69M-137.25M54.64M-1.90B-19.97M33.28M-82.12K-3.09M4.71M-43.34M809.40K
EBITDA Margin41.20%50.76%58.11%44.26%35.62%28.27%17.11%-5.95%-36.58%27.97%-1805.77%-8.72%20.38%-0.08%-4.04%3.42%-31.50%0.40%
Net Income5.11M10.42M22.44M27.03M19.06M9.62M1.79M-35.66M-139.63M7.44M-1.95B-60.79M4.21M-27.30M-31.83M-22.00M-65.95M-27.19M
Net Income Margin22.92%30.90%42.73%35.80%23.25%11.63%1.47%-14.44%-37.21%3.81%-1849.11%-26.55%2.58%-25.29%-41.69%-16.00%-47.93%-13.57%
R&D----898.15K2.08M3.03M3.52M4.94M1.69M1.29M2.10M763.95K1.51M565.27K1.64M1.21M1.02M
R&D as % of Total Revenue----1.10%2.52%2.49%1.43%1.32%0.87%1.22%0.92%0.47%1.40%0.74%1.19%0.88%0.51%
Interest Expense142.56K142.56K916.04K1.60M484.29K558.13K3.09M13.49M19.93M18.08M20.44M15.74M12.61M14.53M14.10M11.00M10.79M9.27M
Interest Expense % of Total Revenue0.64%0.42%1.74%2.12%0.59%0.68%2.54%5.46%5.31%9.26%19.42%6.87%7.72%13.46%18.47%8.00%7.84%4.63%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets56.44M93.52M149.18M173.60M425.17M534.37M610.01M911.91M855.37M690.95M1.40B1.14B907.02M842.79M332.15M315.23M248.20M279.63M
Total Liabilities13.80M14.64M47.86M55.21M34.74M132.28M173.58M497.32M454.33M328.44M1.20B996.65M757.95M728.43M237.98M243.24M242.51M235.08M
Total Equity42.64M78.88M101.32M118.39M389.37M398.98M395.25M351.31M367.65M363.56M209.01M149.22M154.97M104.13M84.26M62.17M-3.78M31.64M
Cash4.67M14.43M31.36M29.57M240.11M209.22M182.58M114.11M162.22M28.50M241.88M22.14M16.30M108.88M47.29M16.73M24.50M39.39M
Total Debt6.12M6.26M37.40M32.27M5.00M7.00M96.04M318.38M313.85M213.71M361.94M204.07M222.19M220.64M181.51M176.82M83.08M-
Net Debt1.45M-8.17M6.04M2.70M-235.11M-202.22M-86.54M204.27M151.64M185.22M120.06M181.94M205.89M36.89M48.64M68.30M58.58M-

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.23M2.62M15.78M38.50M-1.55M-26.99M3.18M-200.05M121.66M78.72M-12.05M-34.94M13.68M-35.06M-7.57M-13.75M14.36M1.95M
Investing Cash Flow-7.85M-4.76M-29.11M-21.56M-203.90M20.53M-54.13M-64.23M-35.56M-31.67M44.43M-12.06M14.76M163.57M-659.23K711.75K149.07K-
Financing Cash Flow15.00M11.90M30.27M-18.74M229.22M1.13M81.36M278.72M-38.57M-158.70M72.26M-73.59M-24.75M-31.13M-55.38M-17.52M-6.74M-
Capital Expenditure7.98M5.10M35.61M23.96M19.53M39.96M91.73M116.91M76.47M18.39M13.95M13.41M13.56M2.09M1.65M1.65M2.68M6.18M
Free Cash Flow-14.21M-2.47M-19.83M14.55M-21.07M-66.94M-88.55M-316.96M45.18M60.33M-26.00M-48.35M122.89K-37.15M-9.22M-15.39M11.67M-4.24M
Dividends Paid--731.17K11.70M7.82M2.37M7.30M15.03M20.86M20.67M21.37M14.03M10.48M10.61M8.79M5.49M5.16M4.51M
FCF to OCF228.07%-94.20%-125.73%37.78%1360.25%248.06%-2780.69%158.44%37.14%76.64%215.73%138.39%0.90%105.95%121.82%111.97%81.32%-217.67%
Dividend Paid to FCF---3.69%80.41%-37.12%-3.54%-8.25%-4.74%46.16%34.26%-82.18%-29.02%8525.20%-28.55%-95.40%-35.70%44.23%-106.33%

Earnings

Report DateAug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 23, 2014Oct 23, 2014Mar 1, 2015Apr 21, 2015Aug 17, 2015Oct 23, 2015Mar 2, 2016Apr 19, 2016Aug 24, 2016Oct 24, 2016Feb 28, 2017Apr 20, 2017Aug 11, 2017Oct 24, 2017Feb 27, 2018Apr 24, 2018Aug 24, 2018Oct 24, 2018Apr 25, 2019Aug 24, 2019Oct 25, 2019Apr 25, 2020Aug 28, 2020Oct 28, 2020Apr 27, 2021Aug 28, 2021Oct 29, 2021Apr 27, 2022Aug 30, 2022Oct 25, 2022Apr 26, 2023Aug 26, 2023Dec 29, 2023Mar 30, 2024Apr 23, 2024Aug 28, 2024Oct 24, 2024Apr 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------
EPS Actual0.040.030.04-0.010.040.020.010.000.030.01-0.02-0.04-0.01-0.02-0.12-0.09-0.07-0.14-0.41-0.020.030.010.02-0.030.070.11-0.03-0.03-0.03-0.11-0.010.01-0.01-0.03-0.04-0.02-0.02-0.05-0.01-0.030.00-0.03-0.02-0.07-0.04-0.08-0.01-0.01-0.050.020.00
Surprise---------------------------------------------------
Timing---------After-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours-------------After-hours-After-hours--------

Key Statistics & Ratios

Market Cap2.89B
Enterprise Value3.19B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales7.64
Price / Book81.51
EPS-0.05
Book Value0.16
Revenue (TTM)378.28M
Gross Profit (TTM)20.77M
EBITDA-6.27M
Profit Margin-4.01%
Operating Margin-0.26%
Return on Equity-52.39%
Return on Assets-4.06%
Shares Outstanding239.78M
Shares Float76.20M
Beta0.23
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20151×
0.03May 8, 2015
20141×
0.03Jun 23, 2014
20121×
0.05Oct 18, 2012

Stock Splits

  • May 8, 201520:10